Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Spero Therapeutics, Inc. (SPRO)

Keutzer Timothy — Chief Operating Officer
Feb 3, 2026
Sale
Shares
24,224
Price
$2.14
Total Value
$51.84K
Shares Held After
764,629
% of Holdings
3.1%
Feb 3, 2026
Sale
Shares
1
Price
$18.00
Total Value
$18.00
Shares Held After
358,233
% of Holdings
0.0%
Feb 3, 2026
Sale
Shares
4,725
Price
$230.77
Total Value
$1.09M
Shares Held After
123,156
% of Holdings
3.7%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Feb 3, 2026
Sale
Shares
4,971
Price
$227.45
Total Value
$1.13M
Shares Held After
52,120
% of Holdings
8.7%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Feb 3, 2026
Sale
Shares
700
Price
$225.25
Total Value
$157.67K
Shares Held After
57,091
% of Holdings
1.2%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Feb 3, 2026
Sale
Shares
1,268
Price
$230.77
Total Value
$292.61K
Shares Held After
57,791
% of Holdings
2.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 3, 2026
Sale
Shares
1,639
Price
$230.77
Total Value
$378.23K
Shares Held After
137,847
% of Holdings
1.2%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Feb 3, 2026
Sale
Shares
2,415
Price
$231.14
Total Value
$558.20K
Shares Held After
178,081
% of Holdings
1.3%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Feb 3, 2026
Sale
Shares
1,179
Price
$230.77
Total Value
$272.08K
Shares Held After
180,496
% of Holdings
0.6%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Feb 3, 2026
Sale
Shares
1,334
Price
$230.77
Total Value
$307.84K
Shares Held After
223,813
% of Holdings
0.6%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Feb 3, 2026
Sale
Shares
435
Price
$230.77
Total Value
$100.38K
Shares Held After
263,161
% of Holdings
0.2%
Feb 3, 2026
Sale
Shares
556
Price
$2.52
Total Value
$1.40K
Shares Held After
186,730
% of Holdings
0.3%
Feb 3, 2026
Sale
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%

Adaptive Biotechnologies Corp (ADPT)

ROBINS HARLAN S — Chief Scientific Officer
Feb 3, 2026
Sale
Shares
8,120
Price
$19.00
Total Value
$154.28K
Shares Held After
1,179,524
% of Holdings
0.7%

UroGen Pharma Ltd. (URGN)

Schoenberg Mark — Chief Medical Officer
Feb 3, 2026
Sale
Shares
3,686
Price
$19.69
Total Value
$72.58K
Shares Held After
144,985
% of Holdings
2.5%

UroGen Pharma Ltd. (URGN)

Schoenberg Mark — Chief Medical Officer
Feb 3, 2026
Sale
Shares
1,843
Price
$19.69
Total Value
$36.29K
Shares Held After
148,671
% of Holdings
1.2%

UroGen Pharma Ltd. (URGN)

Schoenberg Mark — Chief Medical Officer
Feb 3, 2026
Sale
Shares
1,844
Price
$19.69
Total Value
$36.31K
Shares Held After
150,514
% of Holdings
1.2%
Feb 3, 2026
Sale
Shares
29,063
Price
$44.58
Total Value
$1.30M
Shares Held After
3,530,702
% of Holdings
0.8%

Alphatec Holdings, Inc. (ATEC)

Hunsaker Craig E — EVP, PEOPLE & CULTURE
Feb 3, 2026
Sale
Shares
37,358
Price
$14.71
Total Value
$549.54K
Shares Held After
1,173,025
% of Holdings
3.1%
Shares
12,528
Price
$45.27
Total Value
$567.14K
Shares Held After
12,546
% of Holdings
50.0%

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Hodgson Ian — Chief Operating Officer
Feb 3, 2026
Sale
Shares
2,415
Price
$8.09
Total Value
$19.54K
Shares Held After
51,927
% of Holdings
4.4%
Feb 3, 2026
Sale
Shares
3,285
Price
$8.09
Total Value
$26.57K
Shares Held After
95,887
% of Holdings
3.3%
Feb 3, 2026
Sale
Shares
10,500
Price
$9.19
Total Value
$96.50K
Shares Held After
62,278
% of Holdings
14.4%

ZEVRA THERAPEUTICS, INC. (ZVRA)

Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Feb 3, 2026
Sale
Shares
3,000
Price
$9.18
Total Value
$27.55K
Shares Held After
29,590
% of Holdings
9.2%
Feb 3, 2026
Sale
Shares
6,195
Price
$42.84
Total Value
$265.41K
Shares Held After
23,972
% of Holdings
20.5%
Feb 3, 2026
Sale
Shares
108,759
Price
$42.84
Total Value
$4.66M
Shares Held After
183,656
% of Holdings
37.2%

Karyopharm Therapeutics Inc. (KPTI)

Macomber Lori — EVP, CFO & Treasurer
Feb 3, 2026
Sale
Shares
1,626
Price
$6.30
Total Value
$10.24K
Shares Held After
85,105
% of Holdings
1.9%

Hims & Hers Health, Inc. (HIMS)

Okupe Oluyemi — Chief Financial Officer
Feb 3, 2026
Sale
Shares
5,262
Price
$26.44
Total Value
$139.11K
Shares Held After
91,617
% of Holdings
5.4%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Feb 3, 2026
Sale
Shares
795
Price
$155.77
Total Value
$123.84K
Shares Held After
84,112
% of Holdings
0.9%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 3, 2026
Sale
Shares
640
Price
$156.27
Total Value
$100.01K
Shares Held After
56,397
% of Holdings
1.1%

INSMED Inc (INSM)

Lewis William — Director
Feb 3, 2026
Sale
Shares
3,009
Price
$156.34
Total Value
$470.43K
Shares Held After
303,882
% of Holdings
1.0%

INSMED Inc (INSM)

Bonstein Sara — Chief Financial Officer
Feb 3, 2026
Sale
Shares
748
Price
$156.34
Total Value
$116.94K
Shares Held After
79,758
% of Holdings
0.9%

INSMED Inc (INSM)

Adsett Roger — Chief Operating Officer
Feb 3, 2026
Sale
Shares
791
Price
$156.17
Total Value
$123.53K
Shares Held After
106,810
% of Holdings
0.7%

CareDx, Inc. (CDNA)

Novack Jeffrey Adam — Secretary and General Counsel
Feb 3, 2026
Sale
Shares
4,441
Price
$20.56
Total Value
$91.29K
Shares Held After
125,364
% of Holdings
3.4%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Feb 3, 2026
Sale
Shares
7,175
Price
$32.12
Total Value
$230.46K
Shares Held After
108,205
% of Holdings
6.2%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Feb 3, 2026
Sale
Shares
12,446
Price
$32.87
Total Value
$409.10K
Shares Held After
109,087
% of Holdings
10.2%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Feb 3, 2026
Sale
Shares
4,333
Price
$32.12
Total Value
$139.18K
Shares Held After
49,080
% of Holdings
8.1%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — CHIEF COMMERCIAL OFFICER
Feb 3, 2026
Sale
Shares
7,310
Price
$32.12
Total Value
$234.80K
Shares Held After
131,823
% of Holdings
5.3%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Feb 3, 2026
Sale
Shares
7,242
Price
$32.12
Total Value
$232.61K
Shares Held After
112,971
% of Holdings
6.0%
Feb 3, 2026
Sale
Shares
33,635
Price
$32.70
Total Value
$1.10M
Shares Held After
432,886
% of Holdings
7.2%
Feb 3, 2026
Sale
Shares
66,452
Price
$32.06
Total Value
$2.13M
Shares Held After
466,521
% of Holdings
12.5%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — CHIEF MEDICAL OFFICER
Feb 3, 2026
Sale
Shares
6,956
Price
$32.12
Total Value
$223.43K
Shares Held After
107,485
% of Holdings
6.1%
Shares
27,500
Price
$4.24
Total Value
$116.64K
Shares Held After
49,000
% of Holdings
35.9%
Feb 3, 2026
Purchase
Shares
2,177
Price
$21.94
Total Value
$47.76K
Shares Held After
641,682
% of Holdings
0.3%
Feb 3, 2026
Purchase
Shares
2,178
Price
$21.94
Total Value
$47.79K
Shares Held After
641,685
% of Holdings
0.3%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Feb 3, 2026
Purchase
Shares
2,500
Price
$1.38
Total Value
$3.45K
Shares Held After
115,190
% of Holdings
2.2%
Feb 3, 2026
Sale
Shares
50
Price
$474.23
Total Value
$23.71K
Shares Held After
270
% of Holdings
15.6%
Feb 2, 2026
Sale
Shares
266,290
Price
$0.01
Total Value
$3.86K
Shares Held After
25,126,710
% of Holdings
1.0%

WEED, INC. (BUDZ)

BREEN NICOLE M — Director
Feb 2, 2026
Sale
Shares
31,625
Price
$0.04
Total Value
$1.11K
Shares Held After
30,381,968
% of Holdings
0.1%

Spero Therapeutics, Inc. (SPRO)

Keutzer Timothy — Chief Operating Officer
Feb 2, 2026
Sale
Shares
18,891
Price
$2.20
Total Value
$41.56K
Shares Held After
788,853
% of Holdings
2.3%
Version: v26.3.33